menu

CME: The P4 Approach: Revolutionizing Diabetic Macular Edema

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

The P4 Approach: Revolutionizing Diabetic Macular Edema

The P4 Approach: Revolutionizing Diabetic Macular Edema
RestartResume
Could the P4 approach, converging systems biology, technology gains and personalized medicine, revolutionize strategies in Diabetic Macular Edema?

Available credits: 1.00

Time to complete: 60 Minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options for efficient, accurate and reproducible diagnosis and monitoring of ocular conditions. Likewise, diabetes management guidelines and strategies, including pharmacologic treatments and devices, have also evolved, underscoring the importance of cross-disciplinary education and communication, as well as a higher level of participation from the patient.  Treatment and management strategies need to be determined that lower the burden of illness, lower the burden of treatment, and enhance outcomes and overall quality of life for patients.

  • Learning Objectives

    After completing this activity, the participant should be better able to:

    • Discuss the implications of the growing diabetes epidemic and its impact on eye care practice.
    • Describe what constitutes an effective integrated cross-disciplinary management, including the role of the Retina Specialists, General Ophthalmologist, Endocrinologist and the patient.
    • Discuss available and emerging treatments. Explain how to incorporate findings from imaging modalities into clinical practice for diabetic eye diseases, including safety and efficacy from clinical trials and real-world experience.
    • Outline communication strategies for patients to convey study findings, risk factors, and anticipated outcomes, for those already receiving anti-VEGF and those new to treatment to patients.
  • Target Audience

    The educational design of this activity addresses the needs of Ophthalmologist (general/comprehensive), Retinal Specialists, Endocrinologists, primary care physicians, and fellows. This certified CME activity is designed for retina specialists and general ophthalmologists and endocrinologists involved in the management of retinal disease.

  • Disclosure of Conflicts of Interest

    Faculty:
    David Boyer, MD-Retina-Vitreous Associates Medical Group
    Arshad Khanani, MD - Sierra Eye Associates
    Rishi Singh, MD- Cleveland Clinic
    Ehud Ur, MD -Professor of Medicine Director, St. Paul’s Hospital Diabetes Centre

    Disclosures of Conflicts of Interest:
    Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Faculty or Presenter

    Reported Financial Relationship

    David Boyer, MD

    Allegro, Ohr, DigiSight , Alcon, Allergan, Bausch & Lomb, Bayer, Genentech, Novartis, Regeneron, Roche

    Arshad Khanani, MD

    Allergan, Aerpio, Genentech, Novartis, Digisight, Opthea, Opthotech, Thrombogenic, Genentech, Allergan

    Rishi Singh, MD

    Regeneron, Genentech, Bausch and Lomb, Zeiss, Optos, Apellis, Regeneron, Genentech

    Ehud Ur, MD

    Nothing to disclose


    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Planner or Manager

    Reported Financial Relationship

    Lindsay Borvansky

    Nothing to disclose

    Andrea Funk

    Nothing to disclose

    Liddy Knight

    Nothing to disclose

    Sue Silva

    Nothing to disclose

    Disclosure of Unlabeled Use:
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Avlis International Inc. do not recommend the use of any agent outside of the labeled indications. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer:
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • Provider(s)/Educational Partner(s)

    Provider(s)/Educational Partner(s):
    This activity is jointly provided by Global Education Group and Avlis International Inc.

     

    This activity is supported by an independent medical grant from Regeneron Pharmaceuticals, Inc. 

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Avlis International Inc.  Global is accredited by the ACCME to provide continuing medical education for physicians.

    Physician Credit Designation:
    Global Education Group designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Term of Offering:
    This activity was released on 9/25/2018 and is valid for one year. Requests for credit must be made no later than 09/25/2019. 

    Global Contact Information:
    For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

    Instructions for Obtaining Credit:
    In order to receive credit, participants must complete the activity. Participants must also score at least a 70% on the post-test and complete the credit application and evaluation form online. Certificates will be issued upon completion. 

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.